Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Gynecology

Free Subscription Articles published in Cancer Retrieve available abstracts of 52 articles: HTML format Text format

Single Articles

May 2012
1. PRINTZ C
   New cervical cancer screening guidelines published.
   Cancer. 2012;118:2565.
   PubMed     Text format     Related articles   
   
   
   
   April 2012
2. PRINTZ C
   Improved survival, treatment response associated with BRCA2 genetic mutation.
   Cancer. 2012;118:1743.
   PubMed     Text format     Related articles   
   
   
   
   February 2012
3. PRINTZ C
   Depression in Latina survivors of breast cancer affects preventive health screening.
   Cancer. 2012;118:869.
   PubMed     Text format     Related articles   
   
   
   
   January 2012
4. LITTON JK , Ready K, Chen H, Gutierrez-Barrera A, et al
   Earlier age of onset of BRCA mutation-related cancers in subsequent generations.
   Cancer. 2012;118:321-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SCHWARTZ MD , Isaacs C, Graves KD, Poggi E, et al
   Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
   Cancer. 2012;118:510-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. YANG WT , Zheng PS
   Kruppel-like factor 4 function as a tumor suppressor in cervical carcinoma.
   Cancer. 2011 Dec 13. doi: 10.1002/cncr.26698.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. HYMAN DM , Zhou Q, Iasonos A, Grisham RN, et al
   Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
   Cancer. 2011 Dec 2. doi: 10.1002/cncr.26655.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. FERGUSON SE , Urowitz S, Massey C, Wegener M, et al
   Confirmatory factor analysis of the Sexual Adjustment and Body Image Scale in women with gynecologic cancer.
   Cancer. 2011 Dec 2. doi: 10.1002/cncr.26632.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. RAHMAN MT , Nakayama K, Rahman M, Nakayama N, et al
   Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.
   Cancer. 2011 Dec 2. doi: 10.1002/cncr.26598.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TRIVERS KF , Baldwin LM, Miller JW, Matthews B, et al
    Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
    Cancer. 2011;117:5334-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
11. MURPHY CG , Mallam D, Stein S, Patil S, et al
    Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.
    Cancer. 2011 Nov 15. doi: 10.1002/cncr.26654.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. BORGES VF , Schedin PJ
    Pregnancy-associated breast cancer: An entity needing refinement of the definition.
    Cancer. 2011 Nov 15. doi: 10.1002/cncr.26643.
    PubMed     Text format     Related articles   
    
    
    
    
13. BODURKA DC , Deavers MT, Tian C, Sun CC, et al
    Reclassification of serous ovarian carcinoma by a 2-tier system: A Gynecologic Oncology Group Study.
    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26618.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ROSE PG
    Which is the best foot to put forward in recurrent ovarian cancer?
    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26615.
    PubMed     Text format     Related articles   
    
    
    
    
15. SECORD AA , Berchuck A, Higgins RV, Nycum LR, et al
    A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26610.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. SIMONDS HM , Wright JD, du Toit N, Neugut AI, et al
    Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa.
    Cancer. 2011 Nov 9. doi: 10.1002/cncr.26639.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BUZDAR A , Vogel C, Schwartzberg L, Garin A, et al
    Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer.
    Cancer. 2011 Nov 1. doi: 10.1002/cncr.26419.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. SHARMA C , Deutsch I, Horowitz DP, Hershman DL, et al
    Patterns of care and treatment outcomes for elderly women with cervical cancer.
    Cancer. 2011 Oct 28. doi: 10.1002/cncr.26589.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. CHEN X , Xiang YB, Long JR, Cai H, et al
    Genetic polymorphisms in obesity-related genes and endometrial cancer risk.
    Cancer. 2011 Oct 28. doi: 10.1002/cncr.26552.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CHAUDARY N , Pintilie M, Hedley D, Fyles AW, et al
    Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.
    Cancer. 2011 Oct 25. doi: 10.1002/cncr.26635.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BRUFSKY AM , Harker WG, Beck JT, Bosserman L, et al
    Final 5-year results of Z-FAST trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole.
    Cancer. 2011 Oct 10. doi: 10.1002/cncr.26313.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
22. HENSLEY ML , Kravetz S, Jia X, Iasonos A, et al
    Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: A 2-cohort, phase 2 study.
    Cancer. 2011 Sep 20. doi: 10.1002/cncr.26569.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. OLIVER KE , Farley JH
    Deciphering surveillance, epidemiology, and end results data analysis: are we seeing the whole picture?
    Cancer. 2011;117:4112-5.
    PubMed     Text format     Related articles   
    
    
    
    
24. JANG S , Kim YT, Chung HW, Lee KR, et al
    Identification of novel immunogenic human leukocyte antigen-A*2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer.
    Cancer. 2011 Sep 14. doi: 10.1002/cncr.26468.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
25. KIM G , Davidson B, Henning R, Wang J, et al
    Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26449.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. LETOURNEAU JM , Ebbel EE, Katz PP, Oktay KH, et al
    Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer.
    Cancer. 2011 Aug 17. doi: 10.1002/cncr.26403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. MCGONIGLE KF , Muntz HG, Vuky J, Paley PJ, et al
    Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: Results of a Phase 2 Study.
    Cancer. 2011;117:3731-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. PRINTZ C
    ASCO highlights new findings on cancer screening discoveries connected to ovarian, cervical, and prostate cancers.
    Cancer. 2011;117:3627-8.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
29. ZIVANOVIC O , Jacks LM, Iasonos A, Leitao MM Jr, et al
    A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26333.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. FLEMING ND , Agadjanian H, Nassanian H, Miller CW, et al
    Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26329.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KLUKOVITS A , Schally AV, Szalontay L, Vidaurre I, et al
    Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
    Cancer. 2011 Jul 12. doi: 10.1002/cncr.26291.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
32. RYAN P , Mulligan AM, Aronson M, Ferguson SE, et al
    Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
    Cancer. 2011 Jun 30. doi: 10.1002/cncr.26323.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. FERRANDINA G , Petrillo M, Restaino G, Rufini V, et al
    Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?
    Cancer. 2011 Jun 30. doi: 10.1002/cncr.26317.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. LLOMBART-CUSSAC A , Ruiz A, Anton A, Barnadas A, et al
    Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
    Cancer. 2011 Jun 29. doi: 10.1002/cncr.26299.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. MOORE LE , Pfeiffer RM, Zhang Z, Lu KH, et al
    Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.
    Cancer. 2011 Jun 29. doi: 10.1002/cncr.26241.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. CASAGRANDE F , Cocco E, Bellone S, Richter CE, et al
    Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin.
    Cancer. 2011 Jun 20. doi: 10.1002/cncr.26215.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. WESTIN SN , Sun CC, Lu KH, Schmeler KM, et al
    Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.
    Cancer. 2011;117:2659-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. MENG F , Song H, Luo C, Yin M, et al
    Correlation of LAPTM4B polymorphisms with cervical carcinoma.
    Cancer. 2011;117:2652-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. HILL EK , Sandbo S, Abramsohn E, Makelarski J, et al
    Assessing gynecologic and breast cancer survivors' sexual health care needs.
    Cancer. 2011;117:2643-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
40. HAVRILESKY LJ , Pokrzywinski R, Revicki D, Higgins RV, et al
    Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer.
    Cancer. 2011 May 19. doi: 10.1002/cncr.26199.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. CHOI CH , Lee YY, Song TJ, Park HS, et al
    Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.
    Cancer. 2011;117:2104-11.
    PubMed     Text format     Related articles   
    
    
    
    
42. CHENG L , Roth LM, Zhang S, Wang M, et al
    KIT gene mutation and amplification in dysgerminoma of the ovary.
    Cancer. 2011;117:2096-103.
    PubMed     Text format     Related articles   
    
    
    
    
43. WALLACE WH
    Oncofertility and preservation of reproductive capacity in children and young adults.
    Cancer. 2011;117.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. RAMIREZ PT , Jhingran A, Macapinlac HA, Euscher ED, et al
    Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.
    Cancer. 2011;117:1928-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
45. FU S , Hu W, Iyer R, Kavanagh JJ, et al
    Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer.
    Cancer. 2011;117:1661-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BELL JG
    Early detection of ovarian cancer: If only we had a "Pap smear" for this disease.
    Cancer. 2011 Apr 4. doi: 10.1002/cncr.26025.
    PubMed     Text format     Related articles   
    
    
    
    
47. ZIGHELBOIM I , Reinhart AJ, Gao F, Schmidt AP, et al
    DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma.
    Cancer. 2011;117:1446-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
48. GOFF BA , Matthews B, Andrilla CH, Miller JW, et al
    How are symptoms of ovarian cancer managed?: A Study of Primary Care Physicians.
    Cancer. 2011 Mar 16. doi: 10.1002/cncr.26035.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. CHEN MY , Liao WS, Lu Z, Bornmann WG, et al
    Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
    Cancer. 2011 Mar 16. doi: 10.1002/cncr.26073.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. NOAH-VANHOUCKE J , Green LE, Dinh TA, Alperin P, et al
    Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population.
    Cancer. 2011 Mar 14. doi: 10.1002/cncr.25926.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
51. SIMARD EP , Pfeiffer RM, Engels EA
    Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. PIYATHILAKE CJ , Macaluso M, Alvarez RD, Chen M, et al
    A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: